A detailed history of Black Rock Inc. transactions in Stoke Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 5,409,169 shares of STOK stock, worth $61.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,409,169
Previous 3,858,463 40.19%
Holding current value
$61.2 Million
Previous $52.1 Million 40.29%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$11.03 - $17.52 $17.1 Million - $27.2 Million
1,550,706 Added 40.19%
5,409,169 $73.1 Million
Q1 2024

May 10, 2024

BUY
$4.12 - $14.17 $7.41 Million - $25.5 Million
1,798,231 Added 87.28%
3,858,463 $52.1 Million
Q4 2023

Feb 13, 2024

SELL
$3.37 - $5.4 $492,956 - $789,901
-146,278 Reduced 6.63%
2,060,232 $10.8 Million
Q3 2023

Nov 13, 2023

SELL
$3.78 - $11.99 $329,464 - $1.05 Million
-87,160 Reduced 3.8%
2,206,510 $8.69 Million
Q2 2023

Aug 11, 2023

BUY
$7.93 - $13.82 $3.55 Million - $6.19 Million
448,175 Added 24.28%
2,293,670 $24.4 Million
Q1 2023

May 12, 2023

BUY
$7.65 - $10.38 $113,587 - $154,122
14,848 Added 0.81%
1,845,495 $15.4 Million
Q4 2022

Feb 13, 2023

BUY
$7.07 - $15.69 $872,749 - $1.94 Million
123,444 Added 7.23%
1,830,647 $16.9 Million
Q3 2022

Nov 14, 2022

BUY
$12.56 - $22.53 $61,719 - $110,712
4,914 Added 0.29%
1,707,203 $21.9 Million
Q2 2022

Aug 12, 2022

BUY
$10.36 - $23.93 $2.9 Million - $6.7 Million
279,937 Added 19.68%
1,702,289 $22.5 Million
Q1 2022

May 12, 2022

SELL
$17.19 - $26.1 $1.03 Million - $1.56 Million
-59,913 Reduced 4.04%
1,422,352 $29.9 Million
Q4 2021

Feb 10, 2022

BUY
$18.11 - $30.72 $1.25 Million - $2.12 Million
69,147 Added 4.89%
1,482,265 $35.6 Million
Q3 2021

Nov 09, 2021

SELL
$23.65 - $34.44 $2.42 Million - $3.52 Million
-102,321 Reduced 6.75%
1,413,118 $35.9 Million
Q2 2021

Aug 11, 2021

BUY
$30.53 - $41.09 $46.3 Million - $62.3 Million
1,515,439 New
1,515,439 $51 Million

Others Institutions Holding STOK

About Stoke Therapeutics, Inc.


  • Ticker STOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,419,300
  • Market Cap $446M
  • Description
  • Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. I...
More about STOK
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.